Johnson & Johnson Stock News

Dividend growth stocks often outperform other asset classes over long periods. These five blue-chip companies could form the basis of a rock-solid dividend growth portfolio.

The Dow Jones Industrial Average contains shares of 30 companies that lead their respective industries. Now that it no longer sells consumer goods, Johnson & Johnson's dividend growth rate could shift into a higher gear.

COLUMBIA, S.C.--(BUSINESS WIRE)--A South Carolina jury has sided with a cancer patient who sued pharmaceutical giant Johnson & Johnson (NYSE:JNJ) saying use of the company's iconic Baby Powder caused his lung cancer. Jurors awarded Michael Perry and his family $32.6 million in compensatory damages and another $30.7 million in punitive damages. Along with Johnson & Johnson, the jury also found c...

Quality Snapshots evaluate dividend-growth companies based on five quality factors including financial performance, resilience and dividend safety. This healthcare sector overview identifies 26 top quality stocks in the sector. Johnson & Johnson and Zoetis discussed as high-quality, fairly valued healthcare stocks with very different yields and growth rates.

24/7 Wall St. Insights Stocks that consistently raise their dividends offer investors huge total return potential.

Are you starting to get nervous about the frothy stock market and thinking about taking some profits off the table? You're not alone.

Johnson & Johnson is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal actions alleging its Baby Powder and other talc products caused cancer, two people familiar with the matter said.

Johnson & Johnson is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal actions alleging its Baby Powder and other talc products caused cancer, two people familiar with the matter said.